Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis

CompletedOBSERVATIONAL
Enrollment

824

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Perennial Allergic Rhinitis (PAR)
Interventions
DRUG

Beclomethasone Dipropionate (BDP) Nasal Aerosol

BDP nasal aerosol 320 mcg/day will be administered to all patients as 2 sprays in each nostril once daily.

Trial Locations (46)

Unknown

Teva Investigational Site 024, Little Rock

Teva Investigational Site 028, Phoenix

Teva Investigational Site 003, Encinitas

Teva Investigational Site 042, Fresno

Teva Investigational Site 006, Los Angeles

Teva Investigational Site 017, Orange

Teva Investigational Site 007, Palmdale

Teva Investigational Site 021, Paramount

Teva Investigational Site 040, Redwood City

Teva Investigational Site 014, Tallahassee

Teva Investigational Site 010, Tamarac

Teva Investigational Site 038, Albany

Teva Investigational Site 031, Lawrenceville

Teva Investigational Site 035, Savannah

Teva Investigational Site 043, Fort Mitchell

Teva Investigational Site 034, Owensboro

Teva Investigational Site 033, Mandeville

Teva Investigational Site 004, Bethesda

Teva Investigational Site 037, Novi

Teva Investigational Site 026, Omaha

Teva Investigational Site 002, Brick

Teva Investigational Site 019, Corning

Teva Investigational Site 018, New York

Teva Investigational Site 039, Niagara Falls

Teva Investigational Site 011, High Point

Teva Investigational Site 027, Winston-Salem

Teva Investigational Site 030, Winston-Salem

Teva Investigational Site 013, Toledo

Teva Investigational Site 022, Ashland

Teva Investigational Site 016, Eugene

Teva Investigational Site 032, Havertown

Teva Investigational Site 025, Normal Square

Teva Investigational Site 012, Pittsburgh

Teva Investigational Site 023, Upland

Teva Investigational Site 015, Dallas

Teva Investigational Site 029, Dallas

Teva Investigational Site 009, Fort Worth

Teva Investigational Site 020, Houston

Teva Investigational Site 041, San Antonio

Teva Investigational Site 044, San Antonio

Teva Investigational Site 046, San Antonio

Teva Investigational Site 001, Waco

Teva Investigational Site 005, Murray

Teva Investigational Site 045, Newport News

Teva Investigational Site 008, Puyallup

Teva Investigational Site 036, Greenfield

All Listed Sponsors
collaborator

United BioSource, LLC

INDUSTRY

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT01632540 - Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis | Biotech Hunter | Biotech Hunter